The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt

Merck & Co.'s Keytruda in the U.S. starts at $12,000 for a 200 mg dose. Costs go up from there based on the insurer, provider ...

How Merck keeps prices for its blockbuster cancer drug sky high

Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...
The New York Times

A New Shot for Cancer Is Convenient, but Poised to Keep Prices High

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and ...
Santa Rosa Press Democrat

Kaiser Permanente Santa Rosa opens new bigger, brighter infusion clinic for cancer patients

Wesley Falatoonzadeh, a Kaiser Permanente oncology nurse, donned a blue chemotherapy gown this week and carefully prepped a syringe of bortezomib, a targeted cancer drug used to treat Barbara Coe’s ...